Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126850101 | 12685010 | 1 | I | 20160821 | 20160824 | 20160825 | 20160825 | EXP | PHHY2016DE116790 | NOVARTIS | 0.00 | A | F | Y | 0.00000 | 20160825 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126850101 | 12685010 | 1 | PS | RITALIN LA | METHYLPHENIDATE HYDROCHLORIDE | 1 | Unknown | 70 MG, QD (40 MG IN THE MORNING AND 30 MG IN THE AFTERNOON) | 21284 | 70 | MG | EXTENDED RELEASE CAPSULES | QD | ||||||
| 126850101 | 12685010 | 2 | I | CEFURAX | CEFUROXIME AXETIL | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126850101 | 12685010 | 1 | Product used for unknown indication |
| 126850101 | 12685010 | 2 | Lyme disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126850101 | 12685010 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126850101 | 12685010 | Drug ineffective | |
| 126850101 | 12685010 | Drug interaction | |
| 126850101 | 12685010 | Lyme disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126850101 | 12685010 | 1 | 2014 | 0 | ||
| 126850101 | 12685010 | 2 | 20160819 | 0 |